JEANNE HARRIS: Open Payments
NPI 1912540238 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 13 payments from 8 companies in 2025. Trend: 2023 $945 · 2024 $150 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $83 |
| Janssen Biotech, Inc. | 3 | $71 |
| Procept Biorobotics Corporation | 1 | $34 |
| UROGEN PHARMA, INC. | 1 | $27 |
| ABBVIE INC. | 1 | $26 |
| Boston Scientific Corporation | 1 | $23 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $20 |
| Medtronic, Inc. | 1 | $18 |
Products named: ERLEADA, GEMTESA, AQUABEAM ROBOTIC SYSTEM, BOTOX, Advantage System, PYLARIFY, ORGOVYX, INTERSTIM.
Industry payments across FL — which companies pay providers there.
